Company intelligence / Profile preview

EirGen Pharma

Waterford, County Waterford, Ireland

Ownership: Private
Employees: ~293
Development stage: Other

Overview

EirGen Pharma has multiple high-potency oral solid dose molecules commercialized globally, with a particular strength in oncology therapeutics for both human and veterinary applications. Their commercialized programs have received global regulatory approvals, and they are expanding manufacturing and R&D capabilities in Ireland.

Therapeutic areas: OncologyOther
Modalities: Small molecule
Industry: Biotech

Partnerships

Multiple partnerships with leading pharmaceutical companies for drug commercialization and development

Beyond the preview

Go deeper on EirGen Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on EirGen Pharma.

Explore the full profile